ADMA Biologics Inc (ADMA) Stock
Key stats
- Market cap
- $2.93B
- Price / Earnings ratio
- 15.4x
- EPS (TTM)
- $0.79
- Volume
- Loading
- 52-week high
- $20.46
- 52-week low
- $7.21
Source: third-party data provider, as of November 13, 2026
Compare with ADMA
Recent news
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
ADMA
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
ADMA
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know
ADMA
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
ADMANews tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 68.04
- MACD 12/26/9
- 0.68
- EMA 9 of MACD
- 0.52
- MACD histogram
- 0.16
- SMA 50
- $10.42
- Price above SMA 50
- EMA 50
- $10.76
- Price above EMA 50
- SMA 200
- $10.76
- Price above SMA 200
- EMA 200
- $11.88
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.25 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
ADMABrokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
ADMAInvestors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know
Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know
ADMAAdma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
ADMA
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
ADMA
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
ADMA
ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know
ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know
ADMA
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market
ADMA
Why Adma Biologics (ADMA) Dipped More Than Broader Market Today
Why Adma Biologics (ADMA) Dipped More Than Broader Market Today
ADMA
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
ADMANews tone: automated (AI) classification of the article's content, not a price prediction.
About ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Adam S. Grossman | Co-Founder, President, CEO & Director | 1977 |
| Mr. P. Terence Kohler | CFO & Treasurer | — |
| Ms. Kaitlin M. Kestenberg | COO & Senior VP of Compliance | 1987 |
| Dr. Jerrold B. Grossman D.P.S., Ph.D. | Co-Founder & Vice Chairman of the Board | 1948 |
| Mr. Michael Goldstein | General Counsel | — |
| Mr. John Hafl | Executive Director of Sales | — |
| Mr. Skyler Bloom | Senior Director of Business Development & Corporate Strategy | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 68.04
- MACD 12/26/9
- 0.68
- EMA 9 of MACD
- 0.52
- MACD histogram
- 0.16
- SMA 50
- $10.42
- Price above SMA 50
- EMA 50
- $10.76
- Price above EMA 50
- SMA 200
- $10.76
- Price above SMA 200
- EMA 200
- $11.88
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $13.00
- Average
- $13.00
- High
- $13.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -11.0 | +5.2 | ||||||||||
| 2022 | -1.4 | +0.0 | +11.6 | -3.2 | +8.5 | -2.9 | +5.4 | +33.0 | -9.7 | +12.8 | +21.0 | +20.1 |
| 2023 | -4.7 | -5.8 | -6.8 | +0.9 | +19.0 | -8.0 | +13.1 | -7.2 | -8.0 | -4.2 | +5.1 | +18.6 |
| 2024 | +14.1 | +1.1 | +19.6 | -0.3 | +43.2 | +14.0 | +6.3 | +41.2 | +20.6 | -17.5 | +3.8 | -12.9 |
| 2025 | -10.1 | -0.5 | +25.3 | +22.6 | -14.7 | -10.9 | +4.6 | -10.7 | -14.8 | +2.9 | +24.8 | -5.9 |
| 2026 | -3.2 | -11.0 | -45.7 | +12.5 | -24.1 | +5.9 | -1.7 | +7.4 | +7.5 | +14.9 | +19.3 |
